Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARINA-1 in the Prevention of BOS Progression in Bilateral Lung Transplant
NCT05654922Phase 3Recruiting
- Sponsor
- Renovion
- Start
- Apr 2023
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ARINA-1 in Bronchiolitis Obliterans Syndrome (BOS), sponsored by Renovion. Started Apr 2023; status: recruiting.
02
Drugs
ARINA-1
03
Conditions
Bronchiolitis Obliterans Syndrome (BOS)
Beyond the preview
Go deeper on NCT05654922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05654922.